| Página principal > Artículos > Brimonidine-LAPONITE® intravitreal formulation has an ocular hypotensive and neuroprotective effect throughout 6 months of follow-up in a glaucoma animal model > BibTeX |
@article{Rodrigo:107335,
author = "Rodrigo, M.J. and Cardiel, M.J. and Fraile, J.M. and
Mendez-Martinez, S. and Martinez-Rincon, T. and Subias, M.
and Polo, V. and Ruberte, J. and Ramirez, T. and Vispe, E.
and Luna, C. and Mayoral, J.A. and Garcia-Martin, E.",
title = "{Brimonidine-LAPONITE® intravitreal formulation has an
ocular hypotensive and neuroprotective effect throughout 6
months of follow-up in a glaucoma animal model}",
year = "2020",
}